A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma

Author:

Iwamoto HidekiORCID,Suzuki Hiroyuki,Masuda Atsutaka,Sakaue Takahiko,Nakamura Toru,Tanaka Toshimitsu,Sakai Miwa,Imamura Yasuko,Yano Hirohisa,Torimura Takuji,Koga Hironori,Yasuda Kaori,Tsurusaki Masakatsu,Seki Takahiro,Kawaguchi Takumi

Funder

Yasuda Memorial Medical Foundation

Shinnihon Foundation of Advanced Medical Treatment Research

Kurume University

Takeda Science Foundation

National Society of Professional Surveyors

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference37 articles.

1. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update;Kudo;Liver Cancer,2021

2. Evolving therapeutic landscape of advanced hepatocellular carcinoma;Yang;Nat. Rev. Gastroenterol. Hepatol.,2023

3. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy;Patel;Clin. Cancer Res.,2022

4. Adverse effects of anticancer agents that target the VEGF pathway;Chen;Nat. Rev. Clin. Oncol.,2009

5. Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues;Yang;Proc. Natl. Acad. Sci. USA,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3